Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de la Universidad Industrial de Santander. Salud
versión impresa ISSN 0121-0807versión On-line ISSN 2145-8464
Resumen
BUITRAGO-GOMEZ, Nathalia; CAMPO-RIVERA, Natalia; FIGUEROA-TORREGROZA, Lunevar y CASANOVA-VALDERRAMA, María Eugenia. Essential hypertension: which antihypertensive agent to choose?. Rev. Univ. Ind. Santander. Salud [online]. 2022, vol.54, e502. Epub 22-Oct-2022. ISSN 0121-0807. https://doi.org/10.18273/saluduis.54.e:22024.
Introduction:
Systemic arterial hypertension (HT) constitutes the main risk factor for cardiovascular morbidity and mortality at a global level, affecting all ages regardless of gender and ethnicity. Its treatment continues to be a challenge, given the persistence of poor control, especially in countries like Colombia.
Objective:
To show the available evidence regarding the updated treatments of HT and the correct choice of antihypertensive agents according to the individual needs of each patient. Likewise, to consolidate and compare the hypotensive effect of the most used antihypertensive agents.
Methodology:
An advanced search was carried out with the terms DeCS and MeSH: Hypertension, antihypertensive agents, Essential Hypertension and Combination Therapy through the search engines PubMed, Clinical Key, Lilacs, Scielo. A total of 109 articles were selected to prepare the present literature review.
Conclusions:
An individualized hypertension treatment plan leads to the recognition of the different phenotypes, the presence of complications, the gender, and race, which are fundamental aspects to consider when choosing the appropriate antihypertensive agents. These findings allow for the achievement of the desired blood pressure target and leads to reduction and prevention of complications derived from suboptimal control.
Palabras clave : Hypertension; Essential hypertension; Antihypertensive agents.